Elite Pharmaceuticals, Inc. (ELTP)
|Net Income (ttm)||2.63M|
|Trading Day||January 15|
|Day's Range||0.0520 - 0.0550|
|52-Week Range||0.05 - 0.11|
There are no news available yet.
Elite Pharmaceuticals engages in the research, development, manufacture, and licensing of proprietary orally administered controlled-release drug delivery systems and products. The company operates in two segments, Abbreviated New Drug Applications for Generic Products and New Drug Applications for Branded Products. It owns, licenses, and contract manufactures various generic and oral dose pharmaceuticals products, such as Phentermine HCl 37.5mg tablets for the treatment of bariatrics under Adipex-P brand; Hydromorphone HCl 8mg tablets for pain... [Read more...]
Drug Manufacturers-Specialty & Generic
|IPO Date |
Jul 23, 1998
|Stock Exchange |
|Ticker Symbol |
In 2019, ELTP's revenue was $17.99 million, an increase of 137.76% compared to the previous year's $7.57 million. Losses were -$2.24 million, -75.86% less than in 2018.